Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (20)

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial

    International Journal of Cardiology, Vol. 391

  3. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

2022

  1. Atrial myxoma surgery and P-wave remodeling

    PACE - Pacing and Clinical Electrophysiology, Vol. 45, Núm. 9, pp. 1160-1164

2021

  1. Ischemic etiology and prognosis in men and women with acute heart failure

    Journal of Clinical Medicine, Vol. 10, Núm. 8

  2. Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival

    Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21

  3. Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fraction

    Internal Medicine Journal, Vol. 51, Núm. 6, pp. 930-938

  4. Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies

    ESC Heart Failure, Vol. 8, Núm. 3, pp. 2306-2309

2020

  1. Clinical characteristics of patients with sustained ventricular arrhythmias after sacubitril/valsartan initiation

    Heart and Vessels, Vol. 35, Núm. 1, pp. 136-142

  2. The ESC Working Group on Cardiovascular Regenerative and Reparative Medicine

    European heart journal, Vol. 41, Núm. 29, pp. 2721-2723

2019

  1. CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions

    Scientific Reports, Vol. 9, Núm. 1

  2. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction

    Internal Medicine Journal, Vol. 49, Núm. 12, pp. 1505-1513

  3. Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure

    Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314

  4. Prognostic of Interatrial Block after an Acute ST-Segment Elevation Myocardial Infarction

    Cardiology (Switzerland), Vol. 142, Núm. 2, pp. 109-115

2018

  1. Global overview of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) Recommendations: A comprehensive series of challenges and priorities of cardiovascular regenerative medicine

    Circulation Research, Vol. 122, Núm. 2, pp. 199-201

  2. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

2017

  1. Global position paper on cardiovascular regenerative medicine

    European Heart Journal

2016

  1. Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)

    American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584

2014

  1. Cooperative research in biomedicine. Spain's Cardiovascular network, red de investigación cardiovascular

    Revista Espanola de Cardiologia, Vol. 67, Núm. 4, pp. 254-258

2006

  1. Eficacia de la implantación del stent recubierto de rapamicina en pacientes diabéticos con vasos muy pequeños (≤2,25 mm). Subanálisis del estudio DIABETES

    Revista Espanola de Cardiologia, Vol. 59, Núm. 10, pp. 1000-1007